Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

185
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
185
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

53
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
53
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

49
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
49
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

73
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
73
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

70
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
70
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

76
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same author

Practical guide on acute heart failure management: From hospital admission to outpatient care.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

A Multimodal Imaging Approach to Left Ventricular Aneurysms, Pseudoaneurysms, and Diverticula.

JACC. Case reports·2026
Same author

Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis.

European heart journal·2026
Same author

Clonally Related Chronic Myelomonocytic Leukemia and Erdheim-Chester Disease with KRAS Mutation: A Rare and Challenging Case.

Acta medica portuguesa·2026
Same author

Atraumatic Splenic Rupture: A Case Report.

Cureus·2026

Related Experiment Video

Updated: Oct 14, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

306

Palliative Care in Heart Failure: Challenging Prognostication.

Inês Egídio de Sousa1, Ana Pedroso1, Beatriz Chambino1

  • 1Internal Medicine Department, Hospital São Francisco Xavier, Lisbon, PRT.

Cureus
|November 1, 2021
PubMed
Summary

The MAGGIC score accurately predicts heart failure mortality. Key predictors of death include psychotropic medication use and high creatinine levels, while ACEI/ARB use is protective.

Keywords:
heart failuremaggic scoremortalitypalliative careprognostication

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K

Related Experiment Videos

Last Updated: Oct 14, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

306
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K

Area of Science:

  • Cardiology
  • Gerontology
  • Palliative Care

Background:

  • Heart failure (HF) is a chronic, progressive condition associated with high mortality and reduced quality of life (QoL).
  • Palliative care improves outcomes for HF patients, but its adoption is limited by challenges in prognostic decision-making.
  • Accurate mortality prediction is crucial for guiding treatment and care planning in heart failure management.

Purpose of the Study:

  • To evaluate the accuracy of the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score in predicting mortality in acute heart failure patients.
  • To identify independent predictors of one-year and three-year mortality in this patient cohort.
  • To explore the role of specific clinical variables and medications in HF prognosis.

Main Methods:

  • Retrospective study of patients discharged from an Acute Heart Failure Unit over one year.
  • Assessment of MAGGIC score accuracy against observed mortality.
  • Multivariate regression analysis to identify predictors of one- and three-year mortality.

Main Results:

  • The MAGGIC score demonstrated utility in predicting mortality, with no significant difference between observed and predicted three-year mortality (p=0.115).
  • Poor functional status, high New York Heart Association (NYHA) class at discharge, psychotropic medication use, and elevated creatinine were associated with increased mortality.
  • One-year mortality predictors included psychotropic medication use (OR=4.110), ACEI/ARB use (OR=0.297), and admission creatinine (OR=2.473).
  • Three-year mortality predictors were psychotropic medication use (OR=3.330) and ACEI/ARB use (OR=0.285).
  • The one-year mortality model showed good discrimination power (AUC 81%).

Conclusions:

  • The MAGGIC score is a valuable tool for prognostication in acute heart failure.
  • Psychotropic medication use and higher creatinine levels are significant risk factors for mortality, whereas ACEI/ARB use is protective.
  • An individualized, patient-centered approach is essential for care goal setting, integrating prognostic information with patient preferences and needs.